Harrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University School of Medicine, Cleveland, Ohio.
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
JAMA Netw Open. 2022 Feb 1;5(2):e2147903. doi: 10.1001/jamanetworkopen.2021.47903.
Limited data exist regarding the characteristics of hospitals that do and do not participate in voluntary public reporting programs.
To describe hospital characteristics and trends associated with early participation in the American College of Cardiology (ACC) voluntary reporting program for cardiac catheterization-percutaneous coronary intervention (CathPCI) and implantable cardioverter-defibrillator (ICD) registries.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study analyzed enrollment trends and characteristics of hospitals that did and did not participate in the ACC voluntary public reporting program. All hospitals reporting procedure data to the National Cardiovascular Data Registry (NCDR) CathPCI or ICD registries that were eligible for the public reporting program from July 2014 (ie, program launch date) to May 2017 were included. Stepwise logistic regression was used to identify hospital characteristics associated with voluntary participation. Enrollment trends were evaluated considering the date US News & World Report (USNWR) announced that it would credit participating hospitals. Data analysis was performed from March 2017 to January 2018.
Hospital characteristics and participation in the public reporting program.
By May 2017, 561 of 1747 eligible hospitals (32.1%) had opted to participate in the program. Enrollment increased from 240 to 376 hospitals (56.7%) 1 month after the USNWR announcement that program participation would be considered as a component of national hospital rankings. Compared with hospitals that did not enroll, program participants had increased median (IQR) procedural volumes for PCI (481 [280-764] procedures vs 332 [186-569] procedures; P < .001) and ICD (114 [56-220] procedures vs 62 [25-124] procedures; P < .001). Compared with nonparticipating hospitals, an increased mean (SD) proportion of participating hospitals adhered to composite discharge medications after PCI (0.96 [0.03] vs 0.92 [0.07]; P < .001) and ICD (0.88 [0.10] vs 0.81 [0.12]; P < .001). Hospital factors associated with enrollment included participation in 5 or more NCDR registries (odds ratio [OR],1.98; 95% CI, 1.24-3.19; P = .005), membership in a larger hospital system (ie, 3-20 hospitals vs ≤2 hospitals in the system: OR, 2.29; 95% CI, 1.65-3.17; P = .001), participation in an NCDR pilot public reporting program of PCI 30-day readmissions (OR, 2.93; 95% CI, 2.19-3.91; P < .001), university affiliation (vs government affiliation: OR, 3.85, 95% CI, 1.03-14.29; P = .045; vs private affiliation: OR, 2.22; 95% CI, 1.35-3.57; P < .001), Midwest location (vs South: OR, 1.47; 95% CI, 1.06-2.08; P = .02), and increased comprehensive quality ranking (4 vs 1-2 performance stars in CathPCI: OR, 8.08; 95% CI, 5.07-12.87; P < .001; 4 vs 1 performance star in ICD: OR, 2.26; 95% CI, 1.48-3.44; P < .001) (C statistic = 0.829).
This study found that one-third of eligible hospitals participated in the ACC voluntary public reporting program and that enrollment increased after the announcement that program participation would be considered by USNWR for hospital rankings. Several hospital characteristics, experience with public reporting, and quality of care were associated with increased odds of participation.
重要性:关于参与和不参与自愿公开报告计划的医院的特征,目前数据有限。
目的:描述与早期参与美国心脏病学会(ACC)自愿报告计划的心脏导管介入(CathPCI)和植入式心脏复律除颤器(ICD)登记处相关的医院特征和趋势。
设计、地点和参与者:本横断面研究分析了参与和不参与 ACC 自愿公开报告计划的医院的登记趋势和特征。所有有资格参与国家心血管数据注册(NCDR)CathPCI 或 ICD 登记处的程序数据报告的医院,都有资格参与该公共报告计划,时间从 2014 年 7 月(即计划启动日期)到 2017 年 5 月。采用逐步逻辑回归来确定与自愿参与相关的医院特征。考虑到 US 新闻与世界报道(USNWR)宣布将对参与医院进行排名这一因素,评估了登记趋势。数据分析于 2017 年 3 月至 2018 年 1 月进行。
主要结果和措施:医院特征和参与公共报告计划。
结果:到 2017 年 5 月,在 1747 家合格医院中,有 561 家(32.1%)选择参与该计划。在美国新闻与世界报道宣布该计划的参与将被视为国家医院排名的一部分后,参与人数从 240 家增加到 376 家(56.7%)。与未参与的医院相比,计划参与者的 PCI(481[280-764]例 vs 332[186-569]例;P<0.001)和 ICD(114[56-220]例 vs 62[25-124]例;P<0.001)的中位数(IQR)程序量有所增加。与未参与的医院相比,更多的 PCI(0.96[0.03] vs 0.92[0.07];P<0.001)和 ICD(0.88[0.10] vs 0.81[0.12];P<0.001)的计划参与者遵循了综合出院药物治疗。与未参与的医院相比,参与的医院包括参与了 5 个或更多的 NCDR 登记处(比值比[OR],1.98;95%置信区间[CI],1.24-3.19;P=0.005)、属于更大的医院系统(即 3-20 家 vs 系统中≤2 家医院:OR,2.29;95%CI,1.65-3.17;P=0.001)、参与 NCDR 的 PCI 30 天再入院试点公开报告计划(OR,2.93;95%CI,2.19-3.91;P<0.001)、大学附属机构(与政府附属机构相比:OR,3.85;95%CI,1.03-14.29;P=0.045;与私立机构相比:OR,2.22;95%CI,1.35-3.57;P<0.001)、中西部地区(与南部相比:OR,1.47;95%CI,1.06-2.08;P=0.02)和增加的综合质量排名(4 颗 vs CathPCI 的 1-2 颗绩效星:OR,8.08;95%CI,5.07-12.87;P<0.001;4 颗 vs ICD 的 1 颗绩效星:OR,2.26;95%CI,1.48-3.44;P<0.001)(C 统计量=0.829)。
结论和相关性:本研究发现,三分之一的合格医院参与了 ACC 自愿公开报告计划,在美国新闻与世界报道宣布该计划的参与将被用于医院排名后,参与人数增加。几家医院的特征、公开报告的经验和护理质量与参与的几率增加有关。